SEC-sourced researchBeta
SVA
SINOVAC BIOTECH LTD
Company comparison ↗
Data passport
- CIK
- 0001084201
- Exchange
- Nasdaq
- Business activity
- — · SIC 2834
- Financial inputs
- 6/6
- Filing date
- Jun 5, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2023 | 470,170,000.0000 | Jun 5, 2026 |
| December 2024 | 361,374,000.0000 | Jun 5, 2026 |
| December 2025 | 386,013,000.0000 | Jun 5, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 386,013,000.0000 | -198,836,000.0000 | -512,184,000.0000 | 8,541,725,000.0000 | 2,145,473,000.0000 | Jun 5, 2026 |
| December 2024 | 361,374,000.0000 | 40,656,000.0000 | -56,891,000.0000 | 12,337,281,000.0000 | 2,043,851,000.0000 | Jun 5, 2026 |
| December 2023 | 470,170,000.0000 | -120,858,000.0000 | 138,645,000.0000 | — | — | Jun 5, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $386.01M | December 2025 | Jun 5, 2026 | 20-F |
| Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax | $361.37M | December 2024 | Jun 5, 2026 | 20-F |
| Net incomeProfitLoss | -$198.84M | December 2025 | Jun 5, 2026 | 20-F |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$512.18M | December 2025 | Jun 5, 2026 | 20-F |
| Total assetsAssets | $8.54B | December 2025 | Jun 5, 2026 | 20-F |
| Total liabilitiesLiabilities | $2.15B | December 2025 | Jun 5, 2026 | 20-F |